Evidence that the substantia nigra is a site of action for l-DOPA
- 29 June 1988
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 89 (2) , 204-208
- https://doi.org/10.1016/0304-3940(88)90382-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The role of dopamine released from distal and proximal dendrites of nigrostriatal dopaminergic neurons in the control of gaba transmission in the thalamic nucleus ventralis medialis in the catNeuroscience, 1987
- D1 and D2 dopamine agonist synergism: separate sites of action?Trends in Pharmacological Sciences, 1987
- Combined L-Dopa and Bromocriptine Therapy for Parkinsonʼs DiseaseClinical Neuropharmacology, 1987
- Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the ratNeuroscience Letters, 1986
- Evidence for a functional role of dopamine type-1 (D-1) receptors in the substantia nigra of ratsEuropean Journal of Pharmacology, 1986
- Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated ratsEuropean Journal of Pharmacology, 1985
- Suppression of L‐dopa‐induced circling in rats with nigral lesions by blockade of central dopa‐decarboxylaseNeurology, 1984
- Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine SystemScience, 1979
- Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitroNature, 1977
- The mechanisms of action of L-dopa in Parkinson's diseaseLife Sciences, 1974